Placebo Controlled Trial of Botulinum Toxin for Gastroparesis
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
It is hypothesized that in some patients with gastroparesis increased pyloric tone may be a
contributing feature. Botox relaxes the pylorus so that food can empty the stomach more
rapidly. Lesser quality studies have shown that this treatment works in about 40% of
patients, and relieves symptoms for up to 3 months. This study compares this treatment to
placebo (saline) injection. After a 1 month period patients may elect to receive open label
botox who have not received relief from their first injection. Patients symptoms and gastric
emptying are followed for 1 year.
Phase:
N/A
Details
Lead Sponsor:
Temple University
Collaborator:
American College of Gastroenterology
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA